SCHEMBL7255152

SCHEMBL7255152

NCC1(CNS(=O)(=O)C(F)(F)F)CC[S+]([O-])CC1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.39
CNR2 P34972 1/20 0.39
CA2 P00918 2/20 0.32
CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254165 0.78 CYP2C9 (0.42) CYP2C9CNR2CA2
SCHEMBL7253880 0.78 CYP2C9 (0.40) CYP2C9CNR2CA2
SCHEMBL7247683 0.78 CYP2C9 (0.40) CYP2C9CNR2CA2
SCHEMBL7250446 0.77 CYP2C9 (0.39) CYP2C9CNR2
SCHEMBL7249574 0.76 CNR2 (0.45) CYP2C9CNR2
SCHEMBL7252576 0.68
SCHEMBL7254428 0.67 CNR2 (0.52) CYP2C9CNR2
SCHEMBL5386084 0.67 EPHX1 (0.39) CYP2C9CNR2CA2CA1
SCHEMBL7249608 0.67 PAOX (0.31)
SCHEMBL5381166 0.66 EPHX1 (0.38) CYP2C9CNR2CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545022-B1 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders PFIZER INC. 2003-04-08 US disclosed